Streamlining urine drug testing workflow

Phenomenex has introduced Strata-X-Drug B Plus, a solid-phase extraction (SPE) sample preparation product for urine drug testing in clinical and forensic toxicology. An expansion of Phenomenex’s drug testing product line, the new Drug B Plus option joins the original Strata-X-Drug B, which is designated for matrices such as plasma, whole blood and serum.

 

The new Drug B Plus product features Phenomenex’s Solvent Shielding Technology, which enables an enzyme hydrolysis to be carried out directly in the microplate well, reducing transfer steps, time requirements and cost. And the hydrolysis solution can be held for six hours or more, providing flexibility in protocol planning. 

To meet the throughput demands of high-volume drug testing laboratories, Strata-X-Drug B Plus is available in 96-well plate format. The product ensures high recoveries, low variation, time savings and reduced solvent requirements, and its protocol eliminates conditioning and equilibration steps from traditional SPE methods. The new sorbent enables extraction of more than 22 drugs of abuse.

www.phenomenex.com

 

 

 

Other news

Upcoming Events

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

World Congress of the International Federation of Biomedical Laboratory Science (IFBLS)

Palazza dei Congressi of Firenze
22-26 September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30 September - 2 October 2018

Going Overboard with Microbiology - Women and Children First

Merseyside Maritime Museum, Albert Dock, Liverpool
19 October 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2018

Biomarker testing in suspected pre-eclampsia

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.